Since Wnt/β-catenin pathway and RAS regulate positively each other during hypertension, the decreased WNT3A expression may lead to inactivation of RAS which has a major role in the pathophysiology of hypertension. The gene discussed is WNT3A; the disease is hypertensive disorder.